Beverage-makers craft next generation of products targeting weight loss GLP-1 usage, health-driven purchases among reasons consumers seek weight management products With the explosive trend in drugs that stimulate the satiety hormone glucagon-like peptide -1 (GLP-1), and the subsequent rush to market of foods and beverages formulated or promoted to support or replace those drugs, weight management seems to have overtaken the post-COVID focus on immunity when it comes to better-for-you beverages
By 2031, CR drugs are forecast to be the top non-GLP-1R obesity drug type, generating $5.43bn, equivalent to 35% of all sales attributed to non-GLP-1R drugs
That Lilly used such contractual tactics suggests they already had influence over telehealth distribution of official Zepbound behind the scenes
Common and Systemic Side Effects Gastrointestinal Issues: The most common side effect of oral supplementation is mild, transient gastrointestinal (GI) discomfort, which can include mild bloating, cramping, loose stools, or general stomach upset
Latin America Market Insight : Growing fitness culture fuels demand for affordable, multifunctional weight support supplements